Biological and clinical significance of differences between RBC membrane (Rh) and non-membrane (ABH, MN, P) antigenic sites: illegitimate ABO, M-N (T), P (Tja) antigens in malignancy.
D000017:ABO Blood-Group System; D000230:Adenocarcinoma / Q000097:blood; D000251:Adenosine Triphosphatases / Q000097:blood; D000368:Aged; D001789:Blood Group Antigens; D001943:Breast Neoplasms / Q000097:blood; D002462:Cell Membrane / Q000276:immunology; D004247:DNA / Q000276:immunology; D004899:Erythroblastosis, Fetal / Q000276:immunology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008074:Lipoproteins / Q000097:blood; D008951:MNSs Blood-Group System; D009005:Monosaccharides / Q000097:blood; D010127:P Blood-Group System; D011247:Pregnancy; D014176:Protein Biosynthesis; D012313:RNA / Q000276:immunology; D012204:Rh-Hr Blood-Group System; D013274:Stomach Neoplasms / Q000097:blood
D000017:ABO Blood-Group System; D001789:Blood Group Antigens; D008074:Lipoproteins; D008951:MNSs Blood-Group System; D009005:Monosaccharides; D010127:P Blood-Group System; D012204:Rh-Hr Blood-Group System; D012313:RNA; D004247:DNA; D000251:Adenosine Triphosphatases